ZA200904200B - 4-(Heterocyclyl)Alkyl-N-(Arylsulfonyl) Indole compounds and their use as 5-HT6 Ligands - Google Patents

4-(Heterocyclyl)Alkyl-N-(Arylsulfonyl) Indole compounds and their use as 5-HT6 Ligands

Info

Publication number
ZA200904200B
ZA200904200B ZA200904200A ZA200904200A ZA200904200B ZA 200904200 B ZA200904200 B ZA 200904200B ZA 200904200 A ZA200904200 A ZA 200904200A ZA 200904200 A ZA200904200 A ZA 200904200A ZA 200904200 B ZA200904200 B ZA 200904200B
Authority
ZA
South Africa
Prior art keywords
arylsulfonyl
heterocyclyl
ligands
alkyl
indole compounds
Prior art date
Application number
ZA200904200A
Other languages
English (en)
Inventor
Nirogi Ventaka Satya Ramakrishna
Rama Sastri Kambhampati
Amol Dinkar Deshpande
Venkateswarlu Jasti
Original Assignee
Suven Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suven Life Sciences Ltd filed Critical Suven Life Sciences Ltd
Publication of ZA200904200B publication Critical patent/ZA200904200B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
ZA200904200A 2007-01-08 2009-06-15 4-(Heterocyclyl)Alkyl-N-(Arylsulfonyl) Indole compounds and their use as 5-HT6 Ligands ZA200904200B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN44CH2007 2007-01-08

Publications (1)

Publication Number Publication Date
ZA200904200B true ZA200904200B (en) 2010-10-27

Family

ID=38819780

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200904200A ZA200904200B (en) 2007-01-08 2009-06-15 4-(Heterocyclyl)Alkyl-N-(Arylsulfonyl) Indole compounds and their use as 5-HT6 Ligands

Country Status (17)

Country Link
US (1) US20100041669A1 (fr)
EP (1) EP2121602B1 (fr)
JP (1) JP2010515673A (fr)
KR (1) KR101176894B1 (fr)
CN (1) CN101563321B (fr)
AU (1) AU2007343062B2 (fr)
BR (1) BRPI0718736A2 (fr)
CA (1) CA2672190C (fr)
DK (1) DK2121602T3 (fr)
EA (1) EA016015B1 (fr)
ES (1) ES2533902T3 (fr)
IL (1) IL199300A (fr)
MX (1) MX2009006757A (fr)
NO (1) NO341958B1 (fr)
NZ (1) NZ578281A (fr)
WO (1) WO2008084491A1 (fr)
ZA (1) ZA200904200B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8318725B2 (en) 2008-09-17 2012-11-27 Suven Life Sciences Limited Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands
EP3083588B1 (fr) 2013-12-20 2020-12-09 Sunshine Lake Pharma Co., Ltd. Composés hétérocycliques aromatiques et leur utilisation dans les produits pharmaceutiques
EP3166924B1 (fr) * 2014-07-08 2019-02-20 Sunshine Lake Pharma Co., Ltd. Dérivés hétérocycliques aromatiques et leurs applications pharmaceutiques
EP3530651A1 (fr) * 2018-02-21 2019-08-28 Adamed sp. z o.o. Dérivés de l'indole et du benzimidazole comme antagonistes doubles des récepteurs 5-ht2a et 5-ht6
CN111233736B (zh) * 2020-03-16 2021-07-16 东莞市东阳光新药研发有限公司 芳杂环类衍生物的盐及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9820113D0 (en) * 1998-09-15 1998-11-11 Merck Sharp & Dohme Therapeutic agents
JP4184077B2 (ja) * 2000-11-02 2008-11-19 ワイス ５−ヒドロキシトリプトアミン−６リガンドとしての１−アリールまたは１−アルキルスルホニル−ヘテロシクリルベンザゾール
BR0210929A (pt) * 2001-06-07 2004-06-08 Hoffmann La Roche Derivados de indol com afinidade para o receptor 5-ht6
JP4559230B2 (ja) * 2002-11-28 2010-10-06 スベン ライフ サイエンシズ リミティド セロトニン受容体に対する親和性を有する新規ｎ−アリールスルホニル−３−置換されたインドール、その調製方法、それを含有する医薬組成物
SE0302760D0 (sv) * 2003-10-20 2003-10-20 Biovitrum Ab New compounds
CA2655694C (fr) * 2006-07-03 2014-12-16 Biovitrum Ab (Publ) 1,4-indoles substitues utiles pour la modulation du recepteur de 5-ht6

Also Published As

Publication number Publication date
CA2672190A1 (fr) 2008-07-17
JP2010515673A (ja) 2010-05-13
NO341958B1 (no) 2018-03-05
NZ578281A (en) 2011-01-28
CN101563321A (zh) 2009-10-21
NO20092400L (no) 2009-10-02
US20100041669A1 (en) 2010-02-18
KR101176894B1 (ko) 2012-08-30
WO2008084491A1 (fr) 2008-07-17
AU2007343062A1 (en) 2008-07-17
EA200970554A1 (ru) 2009-12-30
MX2009006757A (es) 2009-06-30
EA016015B1 (ru) 2012-01-30
KR20090096513A (ko) 2009-09-10
BRPI0718736A2 (pt) 2014-03-25
DK2121602T3 (en) 2015-04-07
CN101563321B (zh) 2012-05-30
EP2121602B1 (fr) 2015-03-18
IL199300A (en) 2014-03-31
HK1135986A1 (en) 2010-06-18
EP2121602A1 (fr) 2009-11-25
AU2007343062B2 (en) 2011-02-10
CA2672190C (fr) 2013-02-05
ES2533902T3 (es) 2015-04-15

Similar Documents

Publication Publication Date Title
HRP20190016T1 (hr) Heterociklički spojevi i njihova upotreba
ZA201308294B (en) Heterocyclic compounds and their uses
IL206360A0 (en) Quinoline derivatives and their use as fungicides
ZA201006063B (en) Fused heterocyclic derivative and use thereof
IL210412A0 (en) Heterocyclic derivatives and uses thereof
EP2152079A4 (fr) Composés hétérocycliques et utilisations de ceux-ci
HUE043591T2 (hu) Kiterjesztett oldható PH20 polipeptidek és alkalmazásuk
ZA201202489B (en) Novel heterocyclic acrylamides and their use as pharmaceuticals
IL202034A0 (en) Heterocyclic indazole derivatives
IL201830A0 (en) Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
IL207846A0 (en) Arylsulfonyl pyrazoline carboxaidine derivatives as 5-ht6 antagonists
PL2238119T3 (pl) Chinazoliny i pokrewne związki heterocykliczne i ich zastosowanie terapeutyczne
NO20090004A (no) Justerbar svenke
ATE537149T1 (de) Sulfonyl-pyrazolinyl-1-carboxamidinderivate als 5-ht6-antagonisten
EP2089392A4 (fr) Dérivés de 3-(dihydro-1h-pyrazolo ý4,3-d¨pyrimidin-5-yl)-4-propoxybenzènesulfonamide et procédés d'utilisation
ZA200905671B (en) Heterocyclic compounds, compositions comprising them and methods of their use
ATE555785T1 (de) Triazolderivate als smo-antagonisten
ZA201103462B (en) Aryl piperazine and their use as alpha2c antagonists
ATE544752T1 (de) Aryloxyacetamidderivate und ihre verwendung als fungizide
BRPI0821142A2 (pt) derivados heterocíclicos bicíclicos
ATE547407T1 (de) Alkylthiopyrimidine als crth2-antagonisten
ZA201002580B (en) Heterocyclic derivatives
ATE512137T1 (de) Benzoylpiperidinderivate als doppelmodulatoren des 5-ht2a- und des d3-rezeptors
ZA200904200B (en) 4-(Heterocyclyl)Alkyl-N-(Arylsulfonyl) Indole compounds and their use as 5-HT6 Ligands
IL202339A0 (en) Azacyclylbenzamide derivatives as histamine-3 antagonists